Should You Sell Chimerix Inc (CMRX) Stock Wednesday Morning?

Chimerix Inc (CMRX) has fallen Wednesday morning, with the stock falling -3.36% in pre-market trading to 2.59. CMRX's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, Chimerix Inc ranks higher than 27% of stocks. Chimerix Inc has risen 24.07% over the past month, closing at $2.27 on July 20. During this period of time, the stock fell as low as $1.84 and as high as $2.90. CMRX has an average analyst recommendation of Strong Buy. The company has an average price target of $8.25.

CMRX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on CMRX!

See Full CMRX Report

Chimerix Inc has a Long-Term Technical rank of 30. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 70% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, CMRX ranks better than 83% of stocks.

Important Dates for Investors in CMRX:

-Chimerix Inc is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-1.21. -We do not have a set dividend date for Chimerix Inc at this time. Click Here To Get The Full Report on Chimerix Inc (CMRX)